-
-
-
-
-
-
-
INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595 Decreases Neuroinflammation in Patients with Alzheimer’s Disease
-
-
-
-
-
-
1,167,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

